Zimmer Biomet Announces Leadership Transition
Chief Operating Officer Ivan Tornos Appointed President and CEO; Elected to the Board of Directors
Chief Financial Officer Suketu (Suky) Upadhyay's Role Expands to CFO and EVP, Finance, Operations & Supply Chain
Company Reaffirms Full-Year 2023 Finan... Devices, Orthopaedic, Personnel Zimmer Biomet (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 22, 2023 Category: Pharmaceuticals Source Type: news
magAssist's NyokAssist(TM) granted Designation by the FDA as a Breakthrough Device
SUZHOU, China, Aug. 21, 2023 -- (Healthcare Sales & Marketing Network) -- Recently, magAssist's NyokAssist™ Interventional Ventricular Assist Device (hereinafter referred to as NyokAssist™), has been granted designation as a breakthrough device by the U.S... Devices, Interventional, Cardiology, FDA magAssist, NyokAssist, interventional VAD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 21, 2023 Category: Pharmaceuticals Source Type: news
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
STOCKHOLM, Aug. 18, 2023 -- (Healthcare Sales & Marketing Network) -- Calliditas Therapeutics AB (Nasdaq: CALT), (Nasdaq Stockholm: CALTX) ("Calliditas"), today announced that the U.S. Food and Drug Administration (FDA) has accepted the submissi... Biopharmaceuticals Calliditas Therapeutics, TARPEYO, budesonide (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 18, 2023 Category: Pharmaceuticals Source Type: news
AbbVie Announces European Commission Approval of AQUIPTA(R) (atogepant) for the Preventive Treatment of Migraine in Adults
AQUIPTA® (atogepant) is the first and only once-daily oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) in the European Union (EU) approved for the prophylaxis of migraine in adults who have four or more migraine days per month
... Biopharmaceuticals, Neurology, Regulatory AbbVie, AQUIPTA, atogepant, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 17, 2023 Category: Pharmaceuticals Source Type: news
VintaBio Names Jennifer Kingsley Chief Commercial Officer
Kingsley will lead strategic ramp-up of VintaBio's commercial activity
Cell and gene therapy CDMO also hires Ann Lee as Chief of Staff
PHILADELPHIA, Aug. 16, 2023 -- (Healthcare Sales & Marketing Network) -- VintaBio, a life sciences company with un... Biopharmaceuticals, Personnel VintaBio, viral vectors (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 16, 2023 Category: Pharmaceuticals Source Type: news
Vertos Medical Promotes Two Senior Leaders to Newly Created C-Suite Roles
New Chief Commercial Officer and Chief Technology Officer to Head Nationwide Lumbar Spinal Stenosis Treatment Expansion and Innovation Efforts
ALISO VIEJO, Calif., Aug. 15, 2023 -- (Healthcare Sales & Marketing Network) -- Vertos Medical Inc., a leader... Devices, Orthopaedic, Neurosurgery, Personnel Vertos Medical, mild Procedure, lumbar spinal stenosis, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 15, 2023 Category: Pharmaceuticals Source Type: news
Instylla Announces Completion of $30MM EQUITY Financing
Secured financing advances Instylla's clinical trials and commercialization readiness
BEDFORD, Mass., Aug. 15, 2023 -- (Healthcare Sales & Marketing Network) -- Instylla, Inc., a privately held company developing next-generation liquid embolics for per... Devices, Interventional, Venture Capital Instylla , Embrace HES, embolization, liquid embolics, embolotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 15, 2023 Category: Pharmaceuticals Source Type: news
HAPPE Spine Announces First Clinical Use of the INTEGRATE(R)-C Interbody Fusion System
GRAND RAPIDS, Mich., Aug. 14, 2023 -- (Healthcare Sales & Marketing Network) -- HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at th... Devices, Orthopaedic, Neurosurgery HAPPE Spine, INTEGRATE-C, Interbody Fusion System, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 14, 2023 Category: Pharmaceuticals Source Type: news
Zumutor Biologics Inc Announces FDA Clearance of IND Application of ZM008, a Novel Monoclonal Antibody Drug Against Multiple Solid Cancers
BOSTON and BANGALORE. India, Aug. 11, 2023 -- (Healthcare Sales & Marketing Network) -- Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today anno... Biopharmaceuticals, Oncology, FDA Zumutor Biologics, Tumor Micro Environment (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 11, 2023 Category: Pharmaceuticals Source Type: news
Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation
GUANGZHOU, China, Aug. 10, 2023 -- (Healthcare Sales & Marketing Network) -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and prov... Devices, FDA Baird Medical, microwave ablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 10, 2023 Category: Pharmaceuticals Source Type: news
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
Alltrna is advancing a new class of genetic medicines based on the power of tRNA biology to universally treat Stop Codon Disease, which encompasses thousands of genetic diseases caused by a premature termination codon (PTC) mutation and affects approximate... Biopharmaceuticals, Venture Capital Alltrna , Stop Codon Disease, tRNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 9, 2023 Category: Pharmaceuticals Source Type: news
Nyra Medical names Lori Chmura as Chief Executive Officer
Health care executive brings more than 30 years of clinical, business, and operational expertise to company
ATLANTA, Aug. 8, 2023 -- (Healthcare Sales & Marketing Network) -- Nyra Medical, an innovative medical device company developing a next generati... Devices, Interventional, Cardiology, Personnel Nyra Medical, transcatheter mitral valve repair (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 8, 2023 Category: Pharmaceuticals Source Type: news
Kytopen Names Michael Chiu, Ph.D., as Chief Executive Officer
Company Adds Proven Product Development and Commercial Leader as it Accelerates Launch of Flowfect® Cell Engineering Technology
CAMBRIDGE, Mass., Aug. 7, 2023 -- (Healthcare Sales & Marketing Network) -- Kytopen, a biotechnology company that develo... Biopharmaceuticals, Personnel Kytopen, Flowfect, microfluidics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 7, 2023 Category: Pharmaceuticals Source Type: news
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
NEW YORK, Aug. 7, 2023 -- (Healthcare Sales & Marketing Network) -- Ligandal Inc., an early-stage genetic medicine biotechnology company, announces the appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer. Mr. Nuwal brings 20 ... Biopharmaceuticals, Personnel Ligandal (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 7, 2023 Category: Pharmaceuticals Source Type: news
NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101(TM) for Chronic Pain
NRx has Licensed US Patent 8,653,120 for use of D-Cycloserine to treat Chronic Pain
Dr. Vania Apkarian, a world leader in pain and D-Cycloserine (DCS) research, has joined the NRx Scientific Advisory Board
RADNOR, Pa., Aug. 7, 2023 -- (Healthcare Sal... Biopharmaceuticals, Licensing NRx Pharmaceuticals, D-Cycloserine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 7, 2023 Category: Pharmaceuticals Source Type: news
